<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260720070275N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-08-26</date_registration>
      <primary_sponsor>Shahed University</primary_sponsor>
      <public_title>Comparison of the effect of foot and hand reflexology massage on pain intensity and sleep quality in patients undergoing total knee arthroplasty</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of foot and hand reflexology massage on pain intensity and sleep quality in patients undergoing total knee arthroplasty</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-08-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>105</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/91787</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Eligible patients will be assigned to groups using a block randomization method with blocks of three (each block comprising one participant for each of the three groups: foot reflexology, hand reflexology, and routine care/control).
To determine the assignment sequence within each block, random numbers generated via https://www.randomizer.org will be used, with settings configured for a single set of three unique numbers and the "place markers across" option selected to define the sequence across all blocks, Blinding description: The assessment and analysis of the results will be performed by an individual who is blinded to the patients’ group allocation.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: pain intensity  after  total knee Arthroplasty. Condition 2: Sleep Quality  after  total knee Arthroplasty.</hc_freetext>
      <i_freetext>Intervention 1: Intervention Group 1: In addition to receiving standard care, foot reflexology massage will be performed for 10 minutes on the side ipsilateral to the operated knee.                                                     Intervention timing: 4 hours after analgesic administration (intramuscular Pethidine 50 mg) on the day of surgery upon arrival at the ward, as well as on the first and second postoperative days (for a total of 3 sessions). Intervention 2: Intervention Group 2: In addition to receiving standard care, hand reflexology massage will be performed for 10 minutes on the side ipsilateral to the operated knee.                                                     Intervention timing: 4 hours after analgesic administration (intramuscular Pethidine 50 mg) on the day of surgery upon arrival at the ward, as well as on the first and second postoperative days (for a total of 3 sessions). Intervention 3: Control Group: Receives standard care without any intervention.                           Pain intensity and sleep quality will be assessed at the same time points as the intervention groups: 4 hours after analgesic administration (intramuscular Pethidine 50 mg) on the day of surgery upon arrival at the ward, as well as on the first and second postoperative days.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Anonymized individual data—including age, gender, medical history, and education—are shared.

When:
Access begins  after the publication of results.

To whom:
Individuals within the relevant scientific field who intend to study or cite the data are granted access to it.

Conditions:
The use of data to enhance efficiency in similar studies and to accelerate the relevant research process is approved

Where to obtain:
They can access the data By sending a message to the researcher's email address : alirezaoliver1380@gmail.com

How to obtain:
Upon the requester's application for access to the data _whether for reference or study _ the data will be sent to them at the earliest opportunity

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Nasrin  Alaee</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahed University, opposite Holy shrine of Imam Khomeini, Khalij Fars Expressway, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3319118651</zip>
        <telephone>+98 21 5121 2133</telephone>
        <email>alaei@shahed.ac.ir</email>
        <affiliation>Shahed University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Nasrin Alaee</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahed University, opposite Holy shrine of Imam Khomeini, Khalij Fars Expressway, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>331911865</zip>
        <telephone>+98 21 5121 2133</telephone>
        <email>alaei@shahed.ac.ir</email>
        <affiliation>Shahed University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>-Ability to understand and complete the questionnaires and measurement scales-
Age over 40 years
Abbreviated Mental Test Score (AMTS) of 7 or higher for elderly patients aged over 60 years</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>-Absence of knee joint infection, rheumatoid arthritis, or neuropathic diseases--
No history of antidepressant or anticonvulsant medication use
Absence of deep vein thrombosis (DVT), open wounds, or severe varicose veins in the limb ipsilateral to the surgical knee
Absence of upper or lower limb amputation on the side ipsilateral to the operated knee</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M25.56</hc_code>
      <hc_code>G47.01</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Pain in knee</hc_keyword>
      <hc_keyword>Insomnia due to medical condition</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention Group 1: In addition to receiving standard care, foot reflexology massage will be performed for 10 minutes on the side ipsilateral to the operated knee.                                                     Intervention timing: 4 hours after analgesic administration (intramuscular Pethidine 50 mg) on the day of surgery upon arrival at the ward, as well as on the first and second postoperative days (for a total of 3 sessions).</i_keyword>
      <i_keyword>Intervention Group 2: In addition to receiving standard care, hand reflexology massage will be performed for 10 minutes on the side ipsilateral to the operated knee.                                                     Intervention timing: 4 hours after analgesic administration (intramuscular Pethidine 50 mg) on the day of surgery upon arrival at the ward, as well as on the first and second postoperative days (for a total of 3 sessions).</i_keyword>
      <i_keyword>Control Group: Receives standard care without any intervention.                           Pain intensity and sleep quality will be assessed at the same time points as the intervention groups: 4 hours after analgesic administration (intramuscular Pethidine 50 mg) on the day of surgery upon arrival at the ward, as well as on the first and second postoperative days.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain intensity. Timepoint: before intervention , 10 minute after intervention and the day after intervention at the morning for 3 days (total : 9 times). Method of measurement: Pain intensity will be measured using a Visual Analog Scale (VAS), where the patient indicates their pain score on a scale from 0 to 10.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Sleep Quality. Timepoint: On the morning after the intervention, for three consecutive days. Method of measurement: Sleep quality will be evaluated  using the Richards-Campbell  Sleep   Questionnaire . The questionnaire is administered to the patient in the morning to assess the previous night's sleep quality, with scores ranging from 0 (worst) to 100 (best).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahed University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-05-31</approval_date>
        <contact_name>Ethics committee of shahed university</contact_name>
        <contact_address>Shahed University, opposite Holy shrine of Imam Khomeini, Khalij Fars Expressway, Tehran, Iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
